Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with DRMA: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
DRMA
Dermata Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
DRMA
Dermata Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
DRMA, dashed
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,360.04
· delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
DRMA
Dermata Therapeutics, Inc.
Change
0.77
▼
−9.80%
· post 0.80
· delayed
After hours
Nov 5 '26
delayed
Mkt cap
$3.1M
Revenue
—
Revenue
—
vs
Compare
After hours
Nov 5 '26
delayed
LLY
ELI Lilly & Co
vs
DRMA
Dermata Therapeutics, Inc.
1,371.32
▼
−3.29%
post 1,360.04
delayed
Price
0.77
▼
−9.80%
post 0.80
delayed
$1.3T
Mkt cap
$3.1M
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,371.32
▼
−3.29%
vs
DRMA
0.77
▼
−9.80%
After hours
Nov 5 '26
delayed